WADA : H λίστα των απαγορευμένων ουσιών και μεθόδων που θα ισχύσει το 2012

Κυκλοφόρησε η λίστα των απαγορευμένων ουσιών και μεθόδων για το 2012 (ισχύει από 1 Ιανουαρίου 2012). Εμείς θα σας ενημερώσουμε αναλυτικά για τις διαφορές της από το 2011 καθώς και για οτιδήποτε πρέπει να δώσετε ιδιαίτερη προσοχή. Προσοχή η ψευτοεφεδρίνη, που υπάρχει σε πολλά φαρμακευτικά σκευάσματα κρυολογήματος απαγορεύεται.

Με την δημιουργία επιτρεπόμενης δόσης και στην φορμοτερόλη ουσιαστικά επιτρέπεται οι αθλητές να λαμβάνουν μέσω σπρέι – με άλλο τρόπο δεν επιτρέπεται- φαρμακευτική αγωγή για άσθμα, φυσικά στο πλαίσιο της κανονικά συνταγουγραφούμενης δόσης. Μιλάμε για τις εξής ουσίες formoterol, sabutamol and salmetero. Αυτό έγινε καθώς οι περισσότεροι αθλητές είχαν γίνει ασθματικοί (υπάρχει φυσικά και το άσθμα μέγιστης προσπάθειας) και όλοι κατεφευγαν σε συνταγογράφηση ιατρού.

 

 

THE 2012 PROHIBITED LIST

WORLD ANTI-DOPING CODE

Valid 1 January 2012

In accordance with Article 4.2.2 of the World Anti-Doping Code, all Prohibited Substances shall be considered as “Specified Substances” except Substances in classes S1, S2, S4.4, S4.5, S6.a, and Prohibited Methods M1, M2 and M3.

SUBSTANCES AND METHODS PROHIBITED AT ALL TIMES

(IN- AND OUT-OF-COMPETITION)

PROHIBITED SUBSTANCES

S0. NON-APPROVED SUBSTANCES

Any pharmacological substance which is not addressed by any of the subsequent sections of the List and with no current approval by any governmental regulatory health authority for human therapeutic use (e.g drugs under pre-clinical or clinical development or discontinued, designer drugs, veterinary medicines) is prohibited at all times.

S1. ANABOLIC AGENTS

Anabolic agents are prohibited.

1. Anabolic Androgenic Steroids (AAS)

a. Exogenous* AAS, including:

1-androstenediol (5α-androst-1-ene-3β,17β-diol ); 1-androstenedione (5α-androst-1-ene-3,17-dione); bolandiol (estr-4-ene-3β,17β-diol ); bolasterone; boldenone; boldione (androsta-1,4-diene-3,17-dione); calusterone; clostebol; danazol (17α-ethynyl-17β-hydroxyandrost-4-eno[2,3-d]isoxazole); dehydrochlormethyltestosterone (4-chloro-17β-hydroxy-17α-methylandrosta-The 2012 Prohibited List 24 August 2011 3

1,4-dien-3-one); desoxymethyltestosterone (17α-methyl-5α-androst-2-en-17β-ol); drostanolone; ethylestrenol (19-nor-17α-pregn-4-en-17-ol); fluoxymesterone; formebolone; furazabol (17β-hydroxy-17α-methyl-5α-androstano[2,3-c]-furazan); gestrinone; 4-hydroxytestosterone (4,17β-dihydroxyandrost-4-en-3-one); mestanolone; mesterolone; metenolone; methandienone (17β-hydroxy-17α-methylandrosta-1,4-dien-3-one); methandriol; methasterone (2α, 17α-dimethyl-5α-androstane-3-one-17β-ol); methyldienolone (17β-hydroxy-17α-methylestra-4,9-dien-3-one); methyl-1-testosterone (17β-hydroxy-17α-methyl-5α-androst-1-en-3-one); methylnortestosterone (17β-hydroxy-17α-methylestr-4-en-3-one); methyltestosterone; metribolone (methyltrienolone, 17β-hydroxy-17α-methylestra-4,9,11-trien-3-one); mibolerone; nandrolone; 19-norandrostenedione (estr-4-ene-3,17-dione); norboletone; norclostebol; norethandrolone; oxabolone; oxandrolone; oxymesterone; oxymetholone; prostanozol (17β-hydroxy-5α-androstano[3,2-c] pyrazole); quinbolone; stanozolol; stenbolone; 1-testosterone (17β-hydroxy-5α-androst-1-en-3-one); tetrahydrogestrinone (18a-homo-pregna-4,9,11-trien-17β-ol-3-one); trenbolone; and other substances with a similar chemical structure or similar biological effect(s).

b. Endogenous** AAS when administered exogenously:

androstenediol (androst-5-ene-3β,17β-diol); androstenedione (androst-4-ene-3,17-dione); dihydrotestosterone (17β-hydroxy-5α-androstan-3-one); prasterone (dehydroepiandrosterone, DHEA); testosterone

and their metabolites and isomers, including but not limited to:

5α-androstane-3α,17α-diol; 5α-androstane-3α,17β-diol; 5α-androstane-3β,17α-diol; 5α-androstane-3β,17β-diol; androst-4-ene-3α,17α-diol; androst-4-ene-3α,17β-diol; androst-4-ene-3β,17α-diol; androst-5-ene-3α,17α-diol; androst-5-ene-3α,17β-diol; androst-5-ene-3β,17α-diol; 4-androstenediol (androst-4-ene-3β,17β-diol); 5-androstenedione (androst-5-ene-3,17-dione); epi-dihydrotestosterone; epitestosterone; 3α-hydroxy-5α-androstan-17-one; 3β-hydroxy-5α-androstan-17-one; 7α-hydroxy-DHEA ; 7β-hydroxy-DHEA ; 7-keto-DHEA; 19-norandrosterone; 19-noretiocholanolone.

2. Other Anabolic Agents, including but not limited to:

Clenbuterol, selective androgen receptor modulators (SARMs), tibolone, zeranol, zilpaterol.

For purposes of this section:

* “exogenous” refers to a substance which is not ordinarily capable of being produced by the body naturally. The 2012 Prohibited List 24 August 2011 4

** “endogenous” refers to a substance which is capable of being produced by the body naturally.

S2. PEPTIDE HORMONES, GROWTH FACTORS AND RELATED SUBSTANCES

The following substances and their releasing factors are prohibited:

 

1. Erythropoiesis-Stimulating Agents [e.g. erythropoietin (EPO), darbepoetin (dEPO), hypoxia-inducible factor (HIF) stabilizers, methoxy polyethylene glycol-epoetin beta (CERA), peginesatide (Hematide)];

 

 

2. Chorionic Gonadotrophin (CG) and Luteinizing Hormone (LH) in males;

 

 

3. Insulins;

 

 

4. Corticotrophins;

 

 

5. Growth Hormone (GH), Insulin-like Growth Factor-1 (IGF-1), Fibroblast Growth Factors (FGFs), Hepatocyte Growth Factor (HGF), Mechano Growth Factors (MGFs), Platelet-Derived Growth Factor (PDGF), Vascular-Endothelial Growth Factor (VEGF) as well as any other growth factor affecting muscle, tendon or ligament protein synthesis/degradation, vascularisation, energy utilization, regenerative capacity or fibre type switching;

 

and other substances with similar chemical structure or similar biological effect(s).

S3. BETA-2 AGONISTS

All beta-2 agonists (including both optical isomers where relevant) are prohibited except salbutamol (maximum 1600 micrograms over 24 hours), formoterol (maximum 36 micrograms over 24 hours) and salmeterol when taken by inhalation in accordance with the manufacturers’ recommended therapeutic regime.

The presence in urine of salbutamol in excess of 1000 ng/mL or formoterol in excess of 30 ng/mL is presumed not to be an intended therapeutic use of the substance and will be considered as an Adverse Analytical Finding unless the Athlete proves, through a controlled pharmacokinetic study, that the abnormal result was the consequence of the use of the therapeutic inhaled dose up to the maximum indicated above. The 2012 Prohibited List 24 August 2011 5

S4. HORMONE AND METABOLIC MODULATORS

The following are prohibited:

 

1. Aromatase inhibitors including, but not limited to: aminoglutethimide, anastrozole, androsta-1,4,6-triene-3,17-dione (androstatrienedione), 4-androstene-3,6,17 trione (6-oxo), exemestane, formestane, letrozole, testolactone.

 

 

2. Selective estrogen receptor modulators (SERMs) including, but not limited to: raloxifene, tamoxifen, toremifene.

 

 

3. Other anti-estrogenic substances including, but not limited to: clomiphene, cyclofenil, fulvestrant.

 

 

4. Agents modifying myostatin function(s) including, but not limited, to: myostatin inhibitors.

 

 

5. Metabolic modulators: Peroxisome Proliferator Activated Receptor δ (PPARδ) agonists (e.g. GW 1516), PPARδ-AMP-activated protein kinase (AMPK) axis agonists (e.g. AICAR)

 

S5. DIURETICS AND OTHER MASKING AGENTS

Masking agents are prohibited. They include:

Diuretics, desmopressin, plasma expanders (e.g. glycerol; intravenous administration of albumin, dextran, hydroxyethyl starch and mannitol), probenecid; and other substances with similar biological effect(s). Local application of felypressin in dental anaesthesia is not prohibited.

Diuretics include:

Acetazolamide, amiloride, bumetanide, canrenone, chlorthalidone, etacrynic acid, furosemide, indapamide, metolazone, spironolactone, thiazides (e.g. bendroflumethiazide, chlorothiazide, hydrochlorothiazide), triamterene; and other substances with a similar chemical structure or similar biological effect(s) (except drospirenone, pamabrom and topical dorzolamide and brinzolamide, which are not prohibited).

The use In- and Out-of-Competition, as applicable, of any quantity of a substance subject to threshold limits (i.e. formoterol, salbutamol, morphine, cathine, ephedrine, methylephedrine and pseudoephedrine) in conjunction with a diuretic or other masking agent requires the deliverance of a specific Therapeutic Use Exemption for that substance in addition to the one granted for the diuretic or other masking agent. The 2012 Prohibited List 24 August 2011 6

PROHIBITED METHODS

M1. ENHANCEMENT OF OXYGEN TRANSFER

The following are prohibited:

 

1. Blood doping, including the use of autologous, homologous or heterologous blood or red blood cell products of any origin.

 

 

2. Artificially enhancing the uptake, transport or delivery of oxygen, including, but not limited to, perfluorochemicals, efaproxiral (RSR13) and modified haemoglobin products (e.g. haemoglobin-based blood substitutes, microencapsulated haemoglobin products), excluding supplemental oxygen.

 

M2. CHEMICAL AND PHYSICAL MANIPULATION

The following are prohibited:

1. Tampering, or attempting to tamper, in order to alter the integrity and validity of Samples collected during Doping Control is prohibited. These include but are not limited to urine substitution and/or adulteration (e.g. proteases).

2. Intravenous infusions and/or injections of more than 50 mL per 6 hour period are prohibited except for those legitimately received in the course of hospital admissions or clinical investigations.

3. Sequential withdrawal, manipulation and reintroduction of any quantity of whole blood into the circulatory system.

M3. GENE DOPING

The following, with the potential to enhance sport performance, are prohibited:

1. The transfer of nucleic acids or nucleic acid sequences;

2. The use of normal or genetically modified cells. The 2012 Prohibited List 24 August 2011 7

SUBSTANCES AND METHODS

PROHIBITED IN-COMPETITION

In addition to the categories S0 to S5 and M1 to M3 defined above, the following categories are prohibited In-Competition:

PROHIBITED SUBSTANCES

S6. STIMULANTS

All stimulants (including both optical isomers where relevant) are prohibited, except imidazole derivatives for topical use and those stimulants included in the 2012 Monitoring Program*.

Stimulants include:

a: Non-Specified Stimulants:

Adrafinil; amfepramone; amiphenazole; amphetamine; amphetaminil; benfluorex; benzphetamine; benzylpiperazine; bromantan; clobenzorex; cocaine; cropropamide; crotetamide; dimethylamphetamine; etilamphetamine; famprofazone; fencamine; fenetylline; fenfluramine; fenproporex; furfenorex; mefenorex; mephentermine; mesocarb; methamphetamine(d-); p-methylamphetamine; methylenedioxyamphetamine; methylenedioxymethamphetamine; modafinil; norfenfluramine; phendimetrazine; phenmetrazine; phentermine; 4-phenylpiracetam (carphedon); prenylamine; prolintane.

A stimulant not expressly listed in this section is a Specified Substance.

b: Specified Stimulants (examples):

Adrenaline**; cathine***; ephedrine****; etamivan; etilefrine; fenbutrazate; fencamfamin; heptaminol; isometheptene; levmetamfetamine; meclofenoxate; methylephedrine****; methylhexaneamine (dimethylpentylamine); methylphenidate; nikethamide; norfenefrine; octopamine; oxilofrine; parahydroxyamphetamine; pemoline; pentetrazol; phenpromethamine; propylhexedrine; pseudoephedrine*****; selegiline; sibutramine; strychnine; tuaminoheptane; and other substances with a similar chemical structure or similar biological effect(s). The 2012 Prohibited List 24 August 2011 8

* The following substances included in the 2012 Monitoring Program (bupropion, caffeine, nicotine, phenylephrine, phenylpropanolamine, pipradol, synephrine) are not considered as Prohibited Substances.

** Local administration (e.g. nasal, ophthalmologic) of Adrenaline or co-administration with local anaesthetic agents is not prohibited.

*** Cathine is prohibited when its concentration in urine is greater than 5 micrograms per milliliter.

**** Each of ephedrine and methylephedrine is prohibited when its concentration in urine is greater than 10 micrograms per milliliter.

***** Pseudoephedrine is prohibited when its concentration in urine is greater than 150 micrograms per milliliter.

S7. NARCOTICS

The following are prohibited:

Buprenorphine, dextromoramide, diamorphine (heroin), fentanyl and its derivatives, hydromorphone, methadone, morphine, oxycodone, oxymorphone, pentazocine, pethidine.

S8. CANNABINOIDS

Natural (e.g. cannabis, hashish, marijuana) or synthetic delta 9-tetrahydrocannabinol (THC) and cannabimimetics [e.g. “Spice” (containing JWH018, JWH073), HU-210] are prohibited.

S9. GLUCOCORTICOSTEROIDS

All glucocorticosteroids are prohibited when administered by oral, intravenous, intramuscular or rectal routes. The 2012 Prohibited List 24 August 2011 9

SUBSTANCES PROHIBITED IN PARTICULAR SPORTS

P1. ALCOHOL

Alcohol (ethanol) is prohibited In-Competition only, in the following sports. Detection will be conducted by analysis of breath and/or blood. The doping violation threshold (haematological values) is 0.10 g/L.

• Aeronautic (FAI)

• Archery (FITA)

• Automobile (FIA)

• Karate (WKF)

• Motorcycling (FIM)

 

• Powerboating (UIM)

 

P2. BETA-BLOCKERS

Unless otherwise specified, beta-blockers are prohibited In-Competition only, in the following sports.

 

• Aeronautic (FAI)

 

• Archery (FITA) (also prohibited Out-of-Competition)

 

• Automobile (FIA)

 

• Billiards (all disciplines) (WCBS)

 

• Boules (CMSB)

 

• Bridge (FMB)

 

• Darts (WDF)

 

• Golf (IGF)

 

• Ninepin and Tenpin Bowling (FIQ)

 

• Powerboating (UIM)

 

• Shooting (ISSF, IPC) (also prohibited Out-of-Competition)

 

• Skiing/Snowboarding (FIS) in ski jumping, freestyle aerials/halfpipe and snowboard halfpipe/big air

 

Beta-blockers include, but are not limited to, the following:

Acebutolol, alprenolol, atenolol, betaxolol, bisoprolol, bunolol, carteolol, carvedilol, celiprolol, esmolol, labetalol, levobunolol, metipranolol, metoprolol, nadolol, oxprenolol, pindolol, propranolol, sotalol, timolol

 

About triathlonworld

Ο κ. Γιάννης Ψαρέλης είναι από τα ιστορικά στελέχη του Τριάθλου στη χώρα μας έχοντας παρακολουθήσει και συμμετέχει έντονά στη διοικητική ανάπτυξη του αθλήματος. Χρόνια μέλος των εθνικών ομάδων ,εκπρόσωπος των αθλητών στην τεχνική επιτροπή του αθλήματος, υπεύθυνος χάραξης των διαδρομών αγώνων της Ομοσπονδίας μεταξύ των οποίων και της Ολυμπιακής διαδρομής του 2004 στη Βουλιαγμένη,έχει διατελέσει γενικός γραμματέας της Ομοσπονδίας Τριάθλου και εκπρόσωπος αυτής στην Ελληνική Ολυμπιακή Επιτροπή. Έχει πληθώρα προπονητικών πιστοποιήσεων στα αθλήματα αντοχής από εθνικές ομοσπονδίες και συνδέσμους προπονητών. Έχει παρακολουθήσει πλήθος εκπαιδευτικών σεμιναρίων της Διεθνούς Ομοσπονδίας Τριάθλου τόσο για Διοργανωτές Αγώνων όσο και κριτές. Επίσης έχει παρακολουθήσει πολυήμερα σεμινάρια για διοργανωτές αγώνων στη Λοζάνη κάτω από την εποπτεία της ΔΟΕ. Έχει σπουδάσει Χημεία στο Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών. Έχει τους εξής πανεπιστημιακούς μεταπτυχιακούς τίτλους : Αθλητική Διοίκηση (Παν.Lyon1-Masters in Sport Organisations Management – πρόγραμμα αναγνωρισμένο από την Διεθνή Ολυμπιακή Επιτροπή), Αθλητική Διοίκηση (Παν. Leicester), Διοίκηση Επιχειρήσεων (Οικονομικό Πανεπιστήμιο Αθηνών- Executive MBA), Μάρκετινγκ & Επικοινωνία (Οικονομικό Πανεπιστήμιο Αθηνών -MSc in Marketing and communication with New Technologies). Προπονητής Τριάθλου Προπονητής Τριάθλου Ο κ.Γιάννης Ψαρέλης έχει διατελέσει Διοικητικός Υπεύθυνος καθώς και Υπεύθυνος Στρατηγικής & Ανάπτυξης στο Sports Excellence (πρόγραμμα που πραγματοποιείται υπό την επιστημονική επίβλεψη της Α’ Ορθοπαιδικής Κλινικής του ΕΚΠΑ, όντας εγκεκριμένο κέντρο από τον Διεθνή Σύνδεσμο Κέντρων Υψηλού Αθλητισμού) έχοντας την επιστημονική επίβλεψη μέχρι και 1800 επίλεκτων αθλητών και αθλητριών προεθνικών και εθνικών ομάδων έως 18 ετών καθώς και των μελών της Προ-Ολυμπαικής προετοιμασίας για τους ΟΑ του Τόκυο (με μνημόνιο συνεργασίας με την ΕΟΕ). Σε επίπεδο ακαδημαϊκό/ ερευνητικό με σημείο αναφοράς μεταπτυχιακές και διδακτορικές σπουδές ασχολείται κυρίως με την επίδραση των προϊόντων νεοπρενίου/ wetsuit στην κολύμβηση τριαθλητών καθώς και με την μεγιστοποίηση της απόδοσης των αθλητών στο mixed relay του Τριάθλου. Από το 1990 συμμετέχει ως εισηγητής σε πλήθος εκπαιδευτικά προγράμματα επιμόρφωσης προπονητών, καθηγητών Φυσικής Αγωγής, γονέων αλλά και αθλητών είτε αναπτύσσοντας τεχνικά θέματα που αφορούν το Τρίαθλο είτε θέματα που αφορούν την ηθική στον αθλητισμό και το αντι-ντόπινγκ. Αρθογραφεί σε πλήθος αθλητικών ιστοσελίδων και περιοδικών σε θέματα που αφορούν την προπονητική, τους κανονισμούς του Τριάθλου ή θέματα ηθικής/ κοινωνιολογίας του αθλητισμού. Ο ίδιος σε συνεργασία με αθλητικούς φορείς (Ομοσπονδίας, Σωματείων και Αθλητικών Οργανισμών των Δήμων) από το 1990 έως σήμερα έχει σχεδιάσει και διοργανώσει έχοντας την επίβλεψη πάνω από 50 αγώνων σε όλη την Ελλάδα (Αθήνα, Χανιά, Ρέθυμνο, Τρίπολη, Θεσσαλονίκη, Σέρρες, Πιερία κ.λπ.)